May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Hypoxia-Induced COX-2 and VEGF Gene Expression in Retinal Cells: Repression by CGP43182
Author Affiliations & Notes
  • W.J. Lukiw
    Ophthalmology & Neuroscience, Louisiana State University Health Sciences Center, New Orleans, LA, United States
  • A. Ottlecz
    Novartis IBR, Basle, Switzerland
  • G. Lambrou
    Novartis IBR, Basle, Switzerland
  • N.G. Bazan
    Novartis IBR, Basle, Switzerland
  • Footnotes
    Commercial Relationships  W.J. Lukiw, Novartis IBR, Basel Switzerland F; A. Ottlecz, Novartis IBR, Basle, Switzerland E; G. Lambrou, Novartis IBR, Basle, Switzerland E; N.G. Bazan, Novartis IBR, Basle, Switzerland F.
  • Footnotes
    Support  AG18031, NS23002
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 2912. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W.J. Lukiw, A. Ottlecz, G. Lambrou, N.G. Bazan; Hypoxia-Induced COX-2 and VEGF Gene Expression in Retinal Cells: Repression by CGP43182 . Invest. Ophthalmol. Vis. Sci. 2003;44(13):2912.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Up-regulation of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) gene expression are associated with the initiation of neovascularization (NV) in hypoxia triggered retinal cells. This study examined transcription factor (TF) AP-1-, HIF-1- and NF-ΚB-DNA binding in relation to COX-2 and VEGF RNA and protein levels in monkey choroidal endothelial (RF/6A) cells exposed to short periods of hypoxia. We also examined the effects of the carboxamide CGP43182, a secretory phopholipase A2 and NF-ΚB inhibitor, on TF-DNA binding, COX-2 and VEGF activation, prostaglandin E2 (PGE2) release and de novo tube formation. Methods: RF/6A cells were subjected to hypoxia (90% N2/5% CO2/5%O2) for 0, 1 and 3 hours at which times RNA and nucleoproteins were isolated. AP-1-, HIF-1- and NF-ΚB-DNA binding was assayed using gel-shift assay; RNA, cellular protein and PGE2 levels were quantitated using RT-PCR, Western and enzyme-immunoassay, respectively. Results: HIF-1 and NF-ΚB activation and HIF-1- and NF-ΚB-DNA binding immediately preceded up-regulation of COX-2 and VEGF gene expression during hypoxia. COX-2 RNA was elevated after 1 and 3 hours of hypoxia 4- and 5-fold, respectively. VEGF RNA and protein abundance consistently lagged behind COX-2 induction, but each were increased 2- to 3-fold 3 hours post-hypoxia. CGP43182 was found to inhibit NF-ΚB- (but not HIF-1-)-DNA binding, COX-2 and VEGF gene expression, PGE2 release and hypoxia-induced tubular morphogenesis. Conclusions: Increased HIF-1- and NF-ΚB-DNA-binding just before COX-2 expression suggests that these TFs are important precursors to both COX-2 and VEGF induction in hypoxic RF/6A cells. CGP43182 appears to be an effective inhibitor of NF-ΚB-mediated signaling pathways culminating in NV. VEGF expression may be regulated through dual-interdependent mechanisms involving HIF-1 directly and indirectly via NF-ΚB-mediated COX-2 expression and PGE2 production. These data underscore the importance of HIF-1 and NF-ΚB activation in orchestrating genetic programs which culminate in de novo tube formation and retinal NV.

Keywords: neovascularization • transcription factors • hypoxia 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.